Save the date! Thursday 31st October 2024, is when Zymeworks (NYSE: ZYME) will be sharing its eagerly awaited third quarter financial results. Investors and analysts will be able to gain valuable insights into the company's financial performance as the announcement is scheduled after market close.
According to the forecasts of financial experts on Wall Street, the concern is expected to reveal an anticipated $0.40 loss per share for the quarter. Additionally, the firm is poised to disclose a quarterly revenue of $15.3 million.
According to the Wall Street analysts projections, the company is expected to generate a total revenue of $105.42 million for the fiscal year. Additionally, these analysts anticipate that the company will report loss of $1.15 per share during the same period.
In the previous year's corresponding quarter, the company's earnings report revealed a per-share loss of $0.38. Moreover, the company achieved a remarkable total revenue of $16.51 million during that quarter.
The business has scheduled a conference call on 31st October 2024 at 04:30 PM eastern time to discuss Q3 financial results.
Throughout Tuesday's trading, Zymeworks (ZYME) shares fluctuated between $13.20 and $13.74, with a trading volume of 335.70 thousand shares. The stock ended the regular trading session at $13.70, reflecting an increase of 3.47 percent.
